학술논문

A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer
Document Type
Article
Source
In Annals of Oncology September 2016 27(9):1712-1718
Subject
Language
ISSN
0923-7534